Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Clinical trial NCT05840770 · WITHDRAWN

Trial details

NCT number: NCT05840770
Sponsor: City of Hope Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Lung Non-Small Cell Carcinoma Metastatic Malignant Neoplasm in the Brain Stage IV Lung Cancer AJCC v8

Start date: 2025-04-15
Primary completion: 2029-10-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.